Zurich Cantonal Bank’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-9,151
Closed -$637K – 2695
2024
Q3
$637K Buy
9,151
+1,297
+17% +$88.9K ﹤0.01% 1409
2024
Q2
$528K Hold
7,854
– – ﹤0.01% 1453
2024
Q1
$542K Sell
7,854
-448
-5% -$30.2K ﹤0.01% 1417
2023
Q4
$517K Sell
8,302
-2,286
-22% -$128K ﹤0.01% 1474
2023
Q3
$594K Buy
10,588
+1,269
+14% +$71.4K ﹤0.01% 1284
2023
Q2
$470K Buy
9,319
+3,027
+48% +$161K ﹤0.01% 1394
2023
Q1
$343K Hold
6,292
– – ﹤0.01% 1526
2022
Q4
$393K Buy
6,292
+1,625
+35% +$108K ﹤0.01% 1398
2022
Q3
$329K Hold
4,667
– – ﹤0.01% 1445
2022
Q2
$264K Sell
4,667
-341
-7% -$18.7K ﹤0.01% 1628
2022
Q1
$314K Hold
5,008
– – ﹤0.01% 1628
2021
Q4
$280K Buy
5,008
+1,172
+31% +$71.6K ﹤0.01% 1854
2021
Q3
$250K Buy
3,836
+1,378
+56% +$94K ﹤0.01% 1774
2021
Q2
$156K Hold
2,458
– – ﹤0.01% 1974
2021
Q1
$147K Sell
2,458
-620
-20% -$33.7K ﹤0.01% 1959
2020
Q4
$154K Hold
3,078
– – ﹤0.01% 1998
2020
Q3
$157K Hold
3,078
– – ﹤0.01% 1769
2020
Q2
$108K Buy
3,078
+935
+44% +$32.2K ﹤0.01% 1904
2020
Q1
$54K Buy
+2,143
New +$63.7K ﹤0.01% 1914

Other funds holding AXNX

Zurich Cantonal Bank's AXNX Position: Q4 2024 in Review

Zurich Cantonal Bank sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 9,151 shares — an estimated $637K sold.

Zurich Cantonal Bank first reported a position in AXNX in Q1 2020 and held it in 19 quarters. The position peaked at $637K in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Zurich Cantonal Bank reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Zurich Cantonal Bank sold 9,151 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $637K.
  • Zurich Cantonal Bank first reported a position in Axonics, Inc. Common Stock in Q1 2020 and held it in 19 quarters.
  • Zurich Cantonal Bank's Axonics, Inc. Common Stock position peaked at $637K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Zurich Cantonal Bank's 13F filing for Q4 2024, filed 7 Feb 2025.